JP2023015334A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023015334A5 JP2023015334A5 JP2022184220A JP2022184220A JP2023015334A5 JP 2023015334 A5 JP2023015334 A5 JP 2023015334A5 JP 2022184220 A JP2022184220 A JP 2022184220A JP 2022184220 A JP2022184220 A JP 2022184220A JP 2023015334 A5 JP2023015334 A5 JP 2023015334A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- propylene glycol
- acid
- fatty acid
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021079015 | 2021-05-07 | ||
| JP2021079015 | 2021-05-07 | ||
| PCT/JP2022/019540 WO2022234850A1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
| JP2022548967A JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548967A Division JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023015334A JP2023015334A (ja) | 2023-01-31 |
| JP2023015334A5 true JP2023015334A5 (enExample) | 2025-05-16 |
Family
ID=83932759
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548967A Active JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
| JP2022184220A Pending JP2023015334A (ja) | 2021-05-07 | 2022-11-17 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022548967A Active JP7181442B1 (ja) | 2021-05-07 | 2022-05-06 | 環状ペプチド化合物を含む製剤及びその製造方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20240366711A1 (enExample) |
| EP (1) | EP4299069A4 (enExample) |
| JP (2) | JP7181442B1 (enExample) |
| KR (2) | KR20230169093A (enExample) |
| CN (1) | CN117241817A (enExample) |
| AU (1) | AU2022270498A1 (enExample) |
| BR (1) | BR112023019622A2 (enExample) |
| CA (1) | CA3219090A1 (enExample) |
| IL (1) | IL306018A (enExample) |
| MX (1) | MX2023013099A (enExample) |
| TW (1) | TW202308679A (enExample) |
| WO (1) | WO2022234850A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI579296B (zh) | 2011-12-28 | 2017-04-21 | Chugai Pharmaceutical Co Ltd | Cyclization of Peptide Compounds |
| BR112022007535A2 (pt) | 2019-11-07 | 2022-07-12 | Chugai Pharmaceutical Co Ltd | Composto peptídico cíclico tendo ação inibitória de kras |
| AR125800A1 (es) | 2021-05-07 | 2023-08-16 | Chugai Pharmaceutical Co Ltd | Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n |
| KR20250008758A (ko) | 2022-05-06 | 2025-01-15 | 추가이 세이야쿠 가부시키가이샤 | Hras 및 nras에 대한 선택적인 kras 억제 효과를 갖는 고리 화합물 |
| JPWO2024085235A1 (enExample) * | 2022-10-20 | 2024-04-25 | ||
| AU2024257451A1 (en) * | 2023-04-20 | 2025-10-09 | Chugai Seiyaku Kabushiki Kaisha | Method for producing cyclic peptide compound |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2670418A4 (en) * | 2011-02-04 | 2015-06-17 | Aegis Therapeutics Llc | ORAL BIO-AVAILABLE PEPTIDARY MATERIAL COMPOSITIONS AND METHOD THEREFOR |
| EP2681235B1 (en) | 2011-03-04 | 2016-05-04 | New York University | Hydrogen bond surrogate macrocycles as modulators of ras |
| TWI579296B (zh) | 2011-12-28 | 2017-04-21 | Chugai Pharmaceutical Co Ltd | Cyclization of Peptide Compounds |
| DK3215127T3 (da) | 2014-11-07 | 2021-02-01 | Sublimity Therapeutics Ltd | Sammensætninger omfattende cyclosporin |
| EP3442991A4 (en) | 2016-04-15 | 2019-11-20 | RA Pharmaceuticals, Inc. | RAS-BINDING PEPTIDES AND METHODS OF USE |
| US10808010B2 (en) | 2016-08-11 | 2020-10-20 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Peptide inhibitors of phosphoglycerate mutase and methods of use |
| CN110869544B (zh) | 2017-06-09 | 2024-03-08 | 中外制药株式会社 | 膜透过性高的环状肽化合物及包含其的文库 |
| WO2020122182A1 (ja) | 2018-12-12 | 2020-06-18 | 中外製薬株式会社 | 分子内水素結合可能な官能基を有するアミノ酸とそれらのアミノ酸を含むペプチド化合物、およびそれらの製造方法 |
| BR112022007535A2 (pt) * | 2019-11-07 | 2022-07-12 | Chugai Pharmaceutical Co Ltd | Composto peptídico cíclico tendo ação inibitória de kras |
| AR125800A1 (es) * | 2021-05-07 | 2023-08-16 | Chugai Pharmaceutical Co Ltd | Métodos para producir compuestos cíclicos que comprendan residuos de aminoácidos sustituidos con n |
-
2022
- 2022-05-06 KR KR1020237032063A patent/KR20230169093A/ko active Pending
- 2022-05-06 EP EP22798954.8A patent/EP4299069A4/en active Pending
- 2022-05-06 MX MX2023013099A patent/MX2023013099A/es unknown
- 2022-05-06 BR BR112023019622A patent/BR112023019622A2/pt unknown
- 2022-05-06 TW TW111117094A patent/TW202308679A/zh unknown
- 2022-05-06 JP JP2022548967A patent/JP7181442B1/ja active Active
- 2022-05-06 US US18/289,392 patent/US20240366711A1/en active Pending
- 2022-05-06 KR KR1020237001877A patent/KR102582225B1/ko active Active
- 2022-05-06 WO PCT/JP2022/019540 patent/WO2022234850A1/ja not_active Ceased
- 2022-05-06 AU AU2022270498A patent/AU2022270498A1/en active Pending
- 2022-05-06 CA CA3219090A patent/CA3219090A1/en active Pending
- 2022-05-06 IL IL306018A patent/IL306018A/en unknown
- 2022-05-06 CN CN202280029838.6A patent/CN117241817A/zh active Pending
- 2022-11-17 JP JP2022184220A patent/JP2023015334A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023015334A5 (enExample) | ||
| JPWO2022234850A5 (enExample) | ||
| JP4636692B2 (ja) | 長鎖トリグリセリドと親油性界面活性剤とを含有する経口医薬組成物 | |
| TWI358268B (enExample) | ||
| Yang et al. | The effect of oil type on the aggregation stability of nanostructured lipid carriers | |
| Gibson | Lipid-based excipients for oral drug delivery | |
| CA2494762A1 (en) | Pharmaceutical compositions comprising cyclosporin for oral administration | |
| US20090149533A1 (en) | Novel fenofibrate formulations and related methods of treatment | |
| CA2494796A1 (en) | Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant | |
| WO2014132134A1 (en) | A composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same | |
| CN117126069A (zh) | 具有改善的稳定性的制剂 | |
| JP6618488B2 (ja) | テストステロンウンデカノエートの安定な製剤 | |
| WO2015186040A1 (en) | Stable nanoemulsion composition | |
| CN114073681A (zh) | 一种含有多廿烷醇的胶囊内容物及其制备方法和软胶囊剂 | |
| JPWO2009025372A1 (ja) | 還元型補酵素ｑ１０含有組成物及びその安定化方法 | |
| JP2009542782A (ja) | 活性成分の注射可能な持続放出処方剤、およびその調製方法 | |
| JP5497464B2 (ja) | 豆腐用消泡剤組成物 | |
| JP7126930B2 (ja) | ビタミンｅ含有油性組成物 | |
| JP2017214335A (ja) | コエンザイムｑ１０組成物及びそれが充填されたソフトカプセル | |
| JPH10330250A (ja) | メナテトレノン油性製剤 | |
| EP3236780B1 (en) | Use of lecithin to inhibit the crystallisation of lysin | |
| JP6887520B2 (ja) | 経口医薬組成物 | |
| RU2398577C2 (ru) | Новые композиции фенофибрата и соответствующие способы лечения | |
| JP7022973B2 (ja) | ソフトカプセル充填用組成物およびソフトカプセル剤 | |
| JP2020002057A (ja) | ゲラニルゲラニオールを含有する自己乳化性組成物 |